# Lamivudine and Zidovudine

NDC: 33342-003
Generic name: Lamivudine and Zidovudine
Labeler / Manufacturer: Macleods Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20180830

FDA application: ANDA090679

## Active ingredients

- LAMIVUDINE: 150 mg/1
- ZIDOVUDINE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"33342-003"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=33342-003
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=63667952-be01-483e-9887-1d5417e7ec16